期刊文献+

分化型甲状腺癌再次手术的策略及技巧 被引量:4

Strategies and Techniques of Reoperation in Differentiated Thyroid Carcinoma
原文传递
导出
摘要 尽管分化型甲状腺癌(differentiated thyroidcar-cinoma,DTC)大多具有良好的预后,但是较高的术后复发率是不容忽视的事实,其40年累积复发率高达35%,并且有约1/3的复发患者死于该病。手术是治疗DTC最主要和最有效的方式。
出处 《中国普外基础与临床杂志》 CAS 2013年第9期957-961,共5页 Chinese Journal of Bases and Clinics In General Surgery
  • 相关文献

参考文献15

  • 1Mazzaferri EL. Kloos RT. Clinical review 128: current approa- ches to primary therapy for papillary and follicular thyroid cancer l J ]. J Clin Endocrinol Metab, 2001, 86(4): 1447-1463.
  • 2Lee JW, Yoon DY, Choi CS, et al. Anaplastic thyroid carci- noma: computed tomographic differentiation from other thyroid masses [J 1. Acta Radiol, 2008, 49(3): 321-327.
  • 3Roh JL, Kim JM, Park CI. Central compartment reoperation for recurrent/persistent differentiated thyroid cancer: patterns of recurrence, morbidity, and prediction of postoperative hypocal- cemia [J]. Ann SurgOncol, 2011, 18(5): 1312-1318.
  • 4Cooper DS, Doherty GM, Haugen BR, et al. American thyroid association (ATA) guidelines taskforce on thyroid nodules and diff- erentiated thyroid cancer. Revised American thyroid association mana- gement guidelines for patients with thyroid nodules and differentiated thyroid cancer [ J ]. Thyroid, 2009, 19(11): 1167-1214.
  • 5甲状腺结节和分化型甲状腺癌诊治指南[J].中华内分泌代谢杂志,2012,28(10):779-797. 被引量:671
  • 6张桂芝,谭建,刘雪辉,孟召伟.131I治疗分化型甲状腺癌术后患者疗效影响因素研究[J].中华核医学杂志,2010(4):259-263. 被引量:44
  • 7Vergez S, Sarini J, Percodani J, et al. Lymph node management in clinically node-negative patients with papillary thyroid carcinoma [Jl. Eur J Surg Oncol, 2010, 36(8): 777-782.
  • 8葛智成,屈翔,滕长胜,梁宇霆,谭小蕖,张忠涛.USG和增强CT对甲状腺癌与中央区淋巴结转移的研究[J].国际外科学杂志,2012,39(2):87-90. 被引量:4
  • 9Xiao GZ, Gao L. Central lymph node metastasis: is it a reliable indicator of lateral node involvement in papillary thyroid carcinoma ? [J]. World J Surg, 2010, 34(2): 237-241.
  • 10Roh JL, Kim JM, Park CI. Lateral cervical lymph node metastases from papillary thyroid carcinoma: pattern of nodal metastases and optimal strategy for neck dissection [J]. Ann Surg Oncol, 2008, 15(4): 1177-1182.

二级参考文献86

  • 1ZHURui-sen YUYong-li LUHan-kui LUOQuan-yong CHENLi-bo.Clinical study of 312 cases with matastatic differentiated thyroid cancer treated with large doses of ^(131)I[J].Chinese Medical Journal,2005(5):425-428. 被引量:10
  • 2Rovers MM,Schilder AG,Zielhuis GA,Rosenfeld RM,张江平,杨妙丽,张全安.中耳炎[J].国外医学(耳鼻咽喉科学分册),2005,29(3):141-143. 被引量:427
  • 3Davies L,Welch HG.Increasing incidence of thyroid cancer in the United States,1973-2002.J Am Med Assoc,2006,295:2164-2167.
  • 4Cooper DS,Doherty GM,Haugen BR,et al.Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.Thyroid,2006,16:109-142.
  • 5Lundgren CI,Hall P,Dickman PW,et al.Clinically significant prognostic factors for differentiated thyroid carcinoma:a populationbased,nested case-control study.Cancer,2006,106:524-531.
  • 6Jukkola A,Bloigu R,Ebeling T,et al.Prognostic factors in differentiated thyroid carcinomas and their implications for current staging classifications.Endocr Relat Cancer,2004,11:571-579.
  • 7Bilimoria KY,Bentrem DJ,Ko CY,et al.Extent of surgery affects survival for papillary thyroid cancer.Ann Surg,2007,246:375-381.
  • 8Do MY,Rhee Y,Kim DJ,et al.Clinical features of bone metastases resulting from thyroid cancer:a review of 28 patients over a 20-year period.Endocr J,2005,52:701-707.
  • 9Kumar A,Bal CS.Differentiated thyroid cancer.Indian J Pediatr,2003,70:707-713.
  • 10Mazzaferri EL,Robbins RJ,Spencer CA,et al.A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma.J Clin Endocrinol Metab,2003,88:1433-1441.

共引文献900

同被引文献60

  • 1Rovers MM,Schilder AG,Zielhuis GA,Rosenfeld RM,张江平,杨妙丽,张全安.中耳炎[J].国外医学(耳鼻咽喉科学分册),2005,29(3):141-143. 被引量:427
  • 2李新营,王志明,吕新生,李劲东,周乐杜,张鸽文.甲状腺疾病再次手术的原因及并发症分析[J].中国普通外科杂志,2005,14(9):644-647. 被引量:22
  • 3石岚,程波,屈新才,刘春萍,黄韬.甲状腺手术中喉返神经损伤原因及预防[J].中国实用外科杂志,2007,27(11):897-899. 被引量:70
  • 4Dralle H, Sekulla C, Lorenz K, et al. Intraoperative monitoring of the recurrent laryngeal nerve in thyroid surgery [ J ]. World J Surg, 2008, 32(7) :1358-1366.
  • 5Randolph GW, Dralle H, AbduUah H, et al. Eleetrophysiologic recurrent laryngeal nerve monitoring during thyroid and parathyroid surgery: international standards guideline statement [ J ].Laryngoscope, 2011, 121 ( Suppl 1 ) : 1-16.
  • 6Kim MK, Mandel SH, Baloch Z, et al. Morbidity following central compartment reoperation for recurrent oe persistent thyroid cancer[J]. Arch Otolaryngol Head Neck Surg, 2004, 130(10) : 1214-1216.
  • 7Hundahl SA, Cady B, Cunningham MP, et al. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the united states during 1996. U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation study[J]. Cancer, 2000, 89(1) : 202-217.
  • 8Liao S, Shindo M. Management of well-differentiated thyroid cancer [J]. Otolaryngol Clin North A, 2012, 45(5) :1163-1179.
  • 9Hay ID, McConahey WM, Goellner JR. Managing patients with papillary thyroid carcinoma: insights gained from the Mayo Clinicg experience of treating 2512 patients during 1940 through 2000 [J]. Trans Am Clin Climatol Assoc, 2002, 113: 241-260.
  • 10Urken ML. Prognosis and management of invasive papillary thyroid carcinoma[ J ]. Otolaryngol Clin Nortth Am, 2010, 43 ( 2 ): 301- 328.

引证文献4

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部